Improving Outcomes in Functional Single Ventricle and Total Anomalous Pulmonary Venous Connection

2004 ◽  
Vol 78 (5) ◽  
pp. 1688-1695 ◽  
Author(s):  
Andrew J. Lodge ◽  
Jack Rychik ◽  
Susan C. Nicolson ◽  
Richard F. Ittenbach ◽  
Thomas L. Spray ◽  
...  
2012 ◽  
Vol 43 (5) ◽  
pp. 965-970 ◽  
Author(s):  
Takaya Hoashi ◽  
Koji Kagisaki ◽  
Tatsuya Oda ◽  
Masataka Kitano ◽  
Kenichi Kurosaki ◽  
...  

2015 ◽  
Vol 24 (6) ◽  
pp. 581-583
Author(s):  
Junya Sugiura ◽  
Hajime Sakurai ◽  
Toshimichi Nonaka ◽  
Takahisa Sakurai ◽  
Tetsuyoshi Taneichi ◽  
...  

Ultrasound ◽  
2018 ◽  
Vol 26 (1) ◽  
pp. 42-48
Author(s):  
Precylia Fernandes ◽  
Lito Mantagou ◽  
Ram Ramaraj ◽  
Umber Agarwal ◽  
Joyce Su Ling Lim

Introduction A functionally single cardiac ventricle seen on foetal ultrasound scan carries a guarded prognosis. The antenatal diagnosis of anomalous pulmonary venous connection (APVC) remains challenging, if there is no associated structural cardiac abnormality. Antenatally, a combination of complex cardiac anomaly with suspected isomerism should raise the possibility of associated total anomalous pulmonary venous connection (TAPVC). There needs to be a high index of suspicion for TAPVC, in functional single ventricle and suspected isomerism, as this carries a very grim outcome postnatally. We illustrate foetal echocardiographic findings of suspected TAPVC and review outcomes of antenatal versus postnatal diagnosis of TAPVC with functional single ventricle. Methods We retrospectively reviewed our database over 13 years, focusing on foetal cardiac diagnosis, pregnancy outcomes, management and outcomes of livebirths with diagnosis of TAPVC with functional single ventricle. Results Thirteen patients were included in the review. For the nine antenatal patients, three pregnancies were terminated and six babies were born alive (four babies had compassionate care, two babies had cardiac surgery). One baby is alive at 8.5 years, after Fontan surgery. For the four postnatal patients, three babies had compassionate care (one alive at age 8.1 years) and one baby had cardiac surgery (died age nine weeks). Ten of the 13 patients have right atrial isomerism. Of these 10 patients, only two are alive. For the three non-isomeric babies, only one baby is still alive. There is heterogeneity of the type of TAPVC diagnosed with no particular group that offered better survival. Conclusion Antenatal diagnosis of TAPVC, even in the context of functional single ventricle remains challenging. If isomerism is suspected, targeted evaluation of pulmonary venous connection should be done. This combination of cardiac lesion carries a very grim outcome. The ability to make this diagnosis antenatally will add to the information and counselling given to these parents.


2018 ◽  
Vol 08 (03) ◽  
pp. e174-e179
Author(s):  
Misugi Emi ◽  
Noboru Inamura

Background and Objectives When single ventricle (SV) is complicated with total anomalous pulmonary venous connection (TAPVC), the pulmonary vein obstruction (PVO) occurs at a high rate.There are some patients who died from the lethal PVO (l-PVO) which needed PVO release dead due to severe desaturation within 24 hours after birth. The purpose of this study was to find a predictive marker for l-PVO during the fetal period. Methods We enrolled 21 patients diagnosed with SV associated with TAPVC in the antenatal period. Ten patients had supracardiac, five had cardiac, five had infracardiac, and one had mixed TAPVC. We reviewed fetal echocardiography and measured cardiothoracic area ratio (CTAR) and total cardiac dimension (TCD). We divided 21 cases into l-PVO group (6) and non-l-PVO group (15) and compared the fetal echocardiography findings and postnatal prognoses between the groups. Results CTAR at the final fetal echocardiography was 16 to 29% (median: 21) in the l-PVO group and 22 to 38% (median: 28) in the non-l-PVO group (p = 0.01). TCD/week at the final echocardiography was 0.67 to 1.0 (median: 0.77) in the l-PVO group and 0.78 to 1.2 (median: 0.96) in the non-l-PVO group (p = 0.02). Conclusion Reduced CTAR in the antenatal period is a good predictor of l-PVO after birth.


2006 ◽  
Vol 14 (5) ◽  
pp. 367-370 ◽  
Author(s):  
Manvinder S Sachdev ◽  
Pradyumna K Jena ◽  
Renu P Kurup ◽  
Roy Varghese ◽  
R Suresh Kumar ◽  
...  

2019 ◽  
Vol 11 (1) ◽  
pp. 39-48 ◽  
Author(s):  
Bahaaldin Alsoufi ◽  
Courtney McCracken ◽  
Kirk Kanter ◽  
Subhadra Shashidharan ◽  
William Border ◽  
...  

Background: Published palliation outcomes of infants with functional single ventricle (SV) and common atrioventricular septal defect (AVSD) are poor due to associated cardiac and extracardiac anomalies and development of atrioventricular valve (AVV) regurgitation. We report current palliation results. Methods: From 2002 to 2012, 80 infants with functional SV with AVSD underwent multistage palliation. Competing-risks analyses modeled events after first-stage surgery and Glenn (death/transplantation vs next palliation surgery) and examined factors associated with survival and AVV intervention. Results: Sixty-eight (80%) patients received neonatal palliation: modified Blalock-Taussig shunt (n = 33, 41%), Norwood (n = 20, 25%), and pulmonary artery band (n = 15, 19%), whereas 12 (15%) received primary Glenn. On competing-risks analysis, one-year following first-stage surgery, 29% of patients had died or received transplantation and 62% had undergone Glenn. Five years following Glenn, 9% of patients had died or received transplantation and 68% had undergone Fontan. Overall eight-year survival was 64% and was lower in patients with genetic syndromes (53% vs 82%), patients requiring concomitant total anomalous pulmonary venous connection repair (53% vs 69%), and those requiring neonatal palliation (48% vs 100%). Factors associated with mortality were unplanned reoperation (hazard ratio [HR]: 3.7 [1.7-8.0], P = .001) and extracorporeal membrane oxygenation use (HR: 7.1 [3.0-16.6], P < .001). Initial AVV regurgitation ≥ moderate was associated with AVV intervention (HR: 6.2 [2.4-16.1], P = .002) with eight-year freedom from death or AVV intervention of 25% in those patients. Conclusions: Patients with SV with AVSD are a distinct group and commonly have associated cardiac and extracardiac malformations that complicate care and affect survival. The development of AVV regurgitation requiring intervention is common but does not affect survival.


Sign in / Sign up

Export Citation Format

Share Document